Catalyst Wire Dossier Catalyst Wire Dossier

insulin degludec (Tresiba)

insulin degludec · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for insulin degludec (Tresiba), covering 2016-01-15 to 2016-01-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of Explorative Formulations of Insulin Degludec and IDegAsp 50 in Healthy Japanese Subjects [Phase 1]

See pricing